Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $24.74. The company's market cap stands at 140.89B, with a P/E ratio of 19.23 and a dividend yield of 6.86%.
On 2026-06-23, Pfizer(PFE) stock moved within a range of $24.69 to $25.24. With shares now at $24.74, the stock is trading +0.2% above its intraday low and -2.0% below the session's peak.
Trading activity shows a volume of 82.01M, compared to an average daily volume of 49.06M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
PFE News
Nike (NKE) announced on Tuesday that current Chief Financial Officer Matthew Friend is stepping down effective August 17 and will be replaced by Pfizer's (PFE)...
...
The new appointment comes as Nike is struggling to execute a turnaround under Chief Executive Elliott Hill, with sales dropping in the company’s key China marke...
Analyst ratings
59%
of 29 ratingsMore PFE News
Option traders moderately bearish in Pfizer (PFE), with shares down 18c near $24.89. Options volume extremely heavy with 409k contracts traded and puts leading...
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Novo Nordisk's US...
While the study missed its primary overall survival endpoint in the broader patient population, it showed encouraging signals in second-line patients. SigVie-0...
Pfizer reported that its investigational cancer drug sigvotatug vedotin did not meet the primary endpoint in a pivotal Phase 3 trial in non small cell lung canc...
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Eli Lilly didn't make the cut. Grab the names FREE today . Lilly secured f...
Pfizer stock is taking a breather. What’s ahead for PFE stock? What To Watch: Pfizer CFO Transition Impact Pfizer is leaning on continuity here: Guegan has spen...
Key Points Pfizer has leaned on acquisitions in recent years to strengthen its growth prospects. Acquisitions, however, can add costs and lead to inefficiency...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.